Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 2

Cerebral hemodynamic alterations in patients with Covid-19

Pages
435–439
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: An increase in basal cerebral blood velocity and a decrease in vasomotor reactivity rates in patients with Covid-19 can be considered as an indicator of dysfunction of cerebral hemodynamics in the central nervous system and this can be evaluated as a result of endothelial dysfunction.Key words: Covid-19, SARS-Cov-2, blood flow velocity, vasomotor reactivity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Coronavirus 2019 disease (Covid-19) was first seen in December 2019 and afterwards it became pandemic.
📊
Key Findings & Data:Several systemic involvements have been reported in Covid-19 patients.
💡
Conclusion & Impact:Conclusion: An increase in basal cerebral blood velocity and a decrease in vasomotor reactivity rates in patients with Covid-19 can be considered as an indicator of dysfunction of cerebral hemodynamics in the central nervous system and this can be evaluated as a result of endothelial dysfunction.Key words: Covid-19, SARS-Cov-2, blood flow velocity, vasomotor reactivity
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Coronavirus 2019 disease (Covid-19) was first seen in December 2019 and afterwards it became pandemic. Several systemic involvements have been reported in Covid-19 patients. In this study, it was aimed to investigate the cerebrovascular hemodynamics in patients with Covid-19. Materials and methods: The sample of this study included 20 patients hospitalized in our clinic diagnosed with Covid-19 via PCR modality and 20 healthy volunteers of similar age and sex. Bilateral middle cerebral arteries were investigated with transcranial Doppler ultrasonography. Basal cerebral blood flow velocities and vasomotor reactivity rates were determined and statistically compared. Results: When patient and control groups were compared, the mean blood flow velocity was found to be higher in Covid-19 patients than in the healthy volunteers and it was statistically significant (P = 0.00). The mean vasomotor reactivity rates values were found to be lower in the Covid-19 group than the healthy group and was also statistically significant (P = 0.00). Conclusion: An increase in basal cerebral blood velocity and a decrease in vasomotor reactivity rates in patients with Covid-19 can be considered as an indicator of dysfunction of cerebral hemodynamics in the central nervous system and this can be evaluated as a result of endothelial dysfunction.Key words: Covid-19, SARS-Cov-2, blood flow velocity, vasomotor reactivity

🔖

Cite This Article

ÖZTÜRK, B., SONKAYA, A. R., KARADAŞ, Ö. (2022). Cerebral hemodynamic alterations in patients with Covid-19. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 2, 435–439. https://ajindex.com/articles/609607

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T et al. A novel coronavirus associated with severe acute respiratory syndrome. New England journal of medicine. 2003
  2. 348 (20): 1953-1666. doi: 10.1056/NEJMoa030781 2. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, Van Amerongen G et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. The Lancet 2003
  3. 362 (9380): 263-270. doi: 10.1016/S0140-6736(03)13967- 0 3. Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt H-R et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine 2003
  4. 348 (20): 1967-1976. doi: 10.1056/NEJMoa030747 4. De Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C et al. Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. Journal of Virology 2013
  5. 87 (14): 7790-7792. doi: 10.1128/JVI.01244-13 5. Zhou F, Yu T, Du R, Fan G, Liu Y et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020
  6. doi: 10.1016/S0140-6736(20)30566-3 6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020
  7. 323 (13): 1239-1242. doi: 10.1001/jama.2020.2648 7. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of Internal Medicine 2020
  8. 172 (9): 577- 582. doi:10.7326/M20-0504 8. Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2020
  9. 12 (1): 14. doi: 10.3390/v12010014 9. Bohmwald K, Galvez N, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Frontiers in Cellular Neuroscience 2018
  10. doi: 10.3389/ fncel.2018.00386 10. Trujillo H, Caravaca-Fontán F, Sevillano Á, Gutiérrez E, Caro J et al. SARS-CoV-2 infection in hospitalized patients with kidney disease. Kidney International Reports 2020
  11. 5 (6): 905- 909. doi: 10.1016/j.ekir.2020.04.024 11. Colavita F, Lapa D, Carletti F, Lalle E, Bordi L et al. SARS-CoV-2 isolation from ocular secretions of a patien